Cannabis Compliance Inc

Cannabis Compliance Inc

Home » European Union

European Union

APPLICATION OF GMP IN THE CANNABIS INDUSTRY

ABSTRACT Many European Union (EU) countries have legalized or decriminalized the medical use of cannabis to some degree. The advent of broad acceptance of medical cannabis as public opinion shifts in the EU is driving the need for the cannabis industry to implement strict regulatory controls on the production of cannabis products. There is therefore a shift to implementation of GMP (Good Manufacturing Practices) in the cannabis space, most notably in Canada, where medical cannabis production has been legal since 2001 but regulated to a lesser extent than the GMP standard. Due to the lack of regulatory harmonization in the US, this shift to GMP standards for production is expected to impact the US market when medical cannabis laws become regulated federally. The interfaces of medical … [Read more...] about APPLICATION OF GMP IN THE CANNABIS INDUSTRY

Challenges for International Licensing

The business of cannabis in the global environment is on the rise and expanding rapidly and multi-dimensionally. The growing cannabis industry has high economic potential and offers exciting and lucrative opportunities for countries and entrepreneurs. The door is opened, the show is on. What’s next? As for any new industry, this growth phase brings many challenges for players at all levels. Many challenges stem from the very limited experience entrepreneurs, established companies and government authorities have in the regulated cannabis space. Canadian regulators and businesses are ahead of the game due to country wide legalization of cannabis on October 17, 2018, and we can apply that knowledge to the rest of the world. One of the Governments’ goals is to stimulate economic growth … [Read more...] about Challenges for International Licensing

Developing The Preventative Control Plan, Part II

The Preventive Control Plan (PCP) development process is a long and extensive process requiring expertise of personnel from different departments and commitment by senior management for its effective implementation and continued success. The development process starts by assembling a team of Subject Matter Experts from different departments and levels in the organization who are knowledgeable in their areas of work and bring in that knowledge to table. Participation from all departments and tiers in the organization is important to ensure the robustness of the PCP, foster employee cooperation which forms the foundation for a well-rounded Preventive Control Plan. After the team is formed, the next step is to develop SOPs for addressing elements of a PCP. This part is similar to … [Read more...] about Developing The Preventative Control Plan, Part II

Reconsidering International Cannabis Policies: Vote on World Health Organization recommendations delayed

On February 25, 2019 the United Nations Commission on Narcotic Drugs (CND) delayed the vote on recommendations by the World Health Organization (WHO) Expert Committee on Drug Dependence (ECDD) to reschedule cannabis under international conventions. The vote on these recommendations was proposed to occur during the CNDs 62nd session in Vienna, Austria in March. In late January 2019, the WHO ECDD proposed recommendations to the CND that cannabis be rescheduled from the Single Convention on Narcotic Drugs 1961 (1961 Convention) and the Convention on Psychotropic Substances 1971 (1971 Convention). With these recommendations, the cannabis community is overwhelmed with much fervor and excitement. But what does this all mean? Conventions and Controls The CND is a policy making body … [Read more...] about Reconsidering International Cannabis Policies: Vote on World Health Organization recommendations delayed

Cannabis Compliance Inc. speaks to Health Europa Quarterly

Originally published in Health Europa Quarterly In a world rapidly heading towards the legalisation of medical cannabis, issues around compliance are more relevant than ever, as Cannabis Compliance Inc. tells Health Europa Quarterly Cannabis Compliance Inc. (CCI) is one of the first consulting firms to focus on regulatory consulting in the cannabis space. Health Europa Quarterly speaks to Brian Wagner, founder and CEO;Edward Collins, vice-president, global sales and marketing; and Karina Lahnakoski, vice-president, quality and regulatory, about the company’s international expansion plans, quality and regulatory standards, and the challenging world of cannabis compliance. Could you tell us a little about the history of Cannabis Compliance Inc.? Wagner: Commercial cannabis production … [Read more...] about Cannabis Compliance Inc. speaks to Health Europa Quarterly

Audits for Success – Helping You Achieve the End Goal

There are many instances where an audit of your cannabis business is called for. Whether it’s in your journey to becoming a Licence Holder (LH) under the Cannabis Regulations, your mission to become EU-GMP certified or wanting to ensure your cannabis business is on track - audits add huge value to helping achieve your end goal. Across Canada, many cannabis businesses are making fundamental mistakes that can delay or even stop them from being successful. Mistakes can range from minor to critical and everywhere in between and here we highlight some common mistakes being made throughout the industry. Common areas that gaps are being identified during audits: Executive level buy-in – this one can make or break a cannabis business. Company executives must buy-in to the quality culture. … [Read more...] about Audits for Success – Helping You Achieve the End Goal